Pharmacovigilance Europe 2026

Register for

Pharmacovigilance Europe 2026

(15th Annual International Conference and Exhibition on Pharmacovigilance, Drug Safety, Regulatory Affairs, Risk Management and Clinical Trials)

#PVEUROPE2026

20-21 May 2026 | London, UK

Welcome to Europe's Leading Pharmacovigilance Conference & Exhibition

visit www.pveurope.com for updates

(If you require Invoice for Payment please Email: [email protected])

Speaker and Sponsor Proposals are Invited.

Email your abstracts / proposals to [email protected]

Pharmacovigilance Europe 2026 will give its participants an opportunity and a platform to share experiences with the like minded individuals in the field. The conference will also provide an insight into the complexities and challenges impacting public safety and risk management, focusing mainly on drugs, biologics and medical devices and the future of PV in the globalization era.

The conference will bring together industry experts and regulators from 15+ countries to discuss the new updates in PV legislation, operational challenges of implication of these changes, experience of implementing global risk management plans, the best and effective way forward, impact of IT and social media on PV and harmonization of different regulatory bodies.

Key Themes

Explore the impact of PV legislation changes and updates on industries and the best practices

Assuring Compliance and its monitoring

Preparing for PV audit and inspections and the role of QPPV

Risk management plans, strategies and new risk- benefit analysis tools to improve REMS reporting

Implementing risk management and safety surveillance methodologies for medical devices

New approaches for risk minimization and communication

Determining steps and strategies for more transparency and involvement of patients

Discussing the how IT and Social media effect Pharmacovigilance and Adverse events reporting

Discuss and review the use of databases and emerging tools for generation and detection of safety signals

Importance of outsourcing and its effectiveness

Harmonization of regulatory framework- developed and emerging markets

Why Should You Attend

Pharma/BioTech companies are always faced with the challenge to improve quality of the safety data with the ever-increasing quantity of the data. The companies are also left with the challenge to manage the dynamic regulatory requirements. There are still many complexities that the industries and the regulatory authorities have to tackle. With more communication and networking you can expand your knowledge on the key complications currently experienced by various industries and departments and design new strategies to overcome the same.

Who Should Attend

VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Research Scholars and professionals with intermediate to advance knowledge and experience in the following:

• Pharmacovigilance
• Risk management
• Drug safety
• Pharmacoepidemiology
• Drug Research & Development
• Clinical Pharmacology
• Clinical Safety
• Information and Clinical Data Management
• Medical product safety assessment
• Clinical research & safety
• Data analysis
• Information technology
• Medical information
• Health outcomes
• Sales and Marketing
• CRO’s
• Contract Manufacturing

*Graviton International Terms and Conditions (T&C) applicable.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher GRAVITON INTERNATIONAL